Publicacións nas que colabora con Juan María González Lahoz (13)

2012

  1. Short communication: Does interleukin-28b single nucleotide polymorphisms influence the natural history of hepatitis b?

    AIDS Research and Human Retroviruses, Vol. 28, Núm. 10, pp. 1262-1264

2011

  1. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

    AIDS, Vol. 25, Núm. 1, pp. 73-79

  2. Short communication: Severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions

    AIDS Research and Human Retroviruses, Vol. 27, Núm. 9, pp. 965-967

2010

  1. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

    Journal of Antimicrobial Chemotherapy, Vol. 65, Núm. 7, pp. 1486-1492

2009

  1. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 5, pp. 1006-1010

2008

  1. Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir

    Clinical Infectious Diseases, Vol. 46, Núm. 11, pp. 1782-1785

2007

  1. Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

    Journal of Medical Virology, Vol. 79, Núm. 8, pp. 1040-1046

  2. Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 4, pp. 885-888

  3. Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors [6]

    Journal of Antimicrobial Chemotherapy

2004

  1. Evolution of genotypic and phenotypic resistance to enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

    Journal of Medical Virology, Vol. 74, Núm. 1, pp. 21-28

  2. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

    AIDS, Vol. 16, Núm. 14, pp. 1959-1961

  2. Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II

    HIV Clinical Trials, Vol. 3, Núm. 5, pp. 397-402